Precipio, Inc, a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer.
Read More…
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Phone203-787-7888
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.86 million
Profitability
Miscellaneous
Employees42
Next Earnings Date8/21/2019 (Confirmed)
OptionableNot Optionable
Precipio (NASDAQ:PRPO) Frequently Asked Questions
What is Precipio's stock symbol?
Precipio trades on the NASDAQ under the ticker symbol "PRPO."
When did Precipio's stock split? How did Precipio's stock split work?
Precipio shares reverse split before market open on Tuesday, June 6th 2017. The 1-30 reverse split was announced on Thursday, May 25th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 5th 2017. An investor that had 100 shares of Precipio stock prior to the reverse split would have 3 shares after the split.
How were Precipio's earnings last quarter?
Precipio (NASDAQ:PRPO) issued its quarterly earnings data on Thursday, August, 23rd. The biotechnology company reported ($0.15) EPS for the quarter, missing the consensus estimate of $1.93 by $2.08. The biotechnology company had revenue of $0.82 million for the quarter. Precipio had a negative net margin of 614.15% and a negative return on equity of 119.23%. View Precipio's Earnings History.
When is Precipio's next earnings date?
Has Precipio been receiving favorable news coverage?
Media coverage about PRPO stock has trended somewhat positive on Tuesday, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Precipio earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned news stories about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Precipio.
Who are some of Precipio's key competitors?
What other stocks do shareholders of Precipio own?
Who are Precipio's key executives?
Precipio's management team includes the folowing people:
- Mr. Ilan Danieli, Founder, Pres, CEO & Director (Age 47)
- Mr. Carl R. Iberger, CFO & Sec. (Age 66)
- Mr. Ahmed Zaki Sabet, Chief Operating Officer (Age 33)
- Mr. Douglas Sites, VP of Sales
- Mr. Ayman Mohamed, Sr. VP of R&D and Laboratory Operations (Age 34)
Who are Precipio's major shareholders?
Precipio's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (1.32%), SeaCrest Wealth Management LLC (0.92%), Morgan Stanley (0.42%) and BlackRock Inc. (0.23%). Company insiders that own Precipio stock include Ilan Danieli and Randal J Kirk. View Institutional Ownership Trends for Precipio.
Which major investors are selling Precipio stock?
Which major investors are buying Precipio stock?
How do I buy shares of Precipio?
Shares of PRPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Precipio's stock price today?
One share of PRPO stock can currently be purchased for approximately $2.93.
How big of a company is Precipio?
What is Precipio's official website?
How can I contact Precipio?
Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The biotechnology company can be reached via phone at 203-787-7888 or via email at [email protected]
MarketBeat Community Rating for Precipio (NASDAQ PRPO)
MarketBeat's community ratings are surveys of what our community members think about Precipio and other stocks. Vote "Outperform" if you believe PRPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRPO will underperform the S&P 500 over the long term. You may vote once every thirty days.
